Geneos Wealth Management’s Veoneer, Inc. VNE Stock Holding History

Geneos Wealth Management’s Portfolio VNE Stock Details VNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-102	Closed	-$5K	–	2513
2018 Q3	$5K	Buy	+102	New	+$5.24K	﹤0.01%	2088

Other funds holding VNE

CCI

Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Geneos Wealth Management's VNE Position: Q4 2018 in Review

Geneos Wealth Management sold out of Veoneer, Inc. (VNE) in Q4 2018, closing a stake of 102 shares — an estimated $5K sold.

Geneos Wealth Management first reported a position in VNE in Q3 2018 and held it in 1 quarter. The position peaked at $5K in Q3 2018. 142 funds tracked by Wall St. Rank hold VNE as of Q4 2018.

Geneos Wealth Management reported no remaining Veoneer, Inc. position as of Q4 2018 after selling out during the quarter.
Geneos Wealth Management sold 102 Veoneer, Inc. shares in Q4 2018, an estimated $5K.
Geneos Wealth Management first reported a position in Veoneer, Inc. in Q3 2018 and held it in 1 quarter.
Geneos Wealth Management's Veoneer, Inc. position peaked at $5K in Q3 2018.
142 funds tracked by Wall St. Rank held Veoneer, Inc. as of Q4 2018.

Based on Geneos Wealth Management's 13F filing for Q4 2018, filed 7 Sep 2021.